Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VERA | US
-0.91
-2.18%
Healthcare
Biotechnology
30/06/2024
04/10/2024
40.84
40.93
41.53
39.92
Vera Therapeutics Inc. a clinical stage biotechnology company focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868 a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair Inc. and changed its name to Vera Therapeutics Inc. in April 2020. Vera Therapeutics Inc. was incorporated in 2016 and is headquartered in Brisbane California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
55.1%1 month
54.1%3 months
47.2%6 months
56.3%-
-
7.26
0.16
0.13
-3.60
-
-
-90.73M
2.35B
2.35B
-
-
-
-
-46.05
16.11
16.58
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
7.38
Range1M
12.00
Range3M
13.61
Rel. volume
0.71
Price X volume
18.66M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
IDEAYA Biosciences Inc | IDYA | Biotechnology | 29.97 | 2.53B | -5.46% | n/a | 0.20% |
Veracyte Inc | VCYT | Biotechnology | 32.84 | 2.52B | -2.83% | n/a | 1.83% |
ACADIA Pharmaceuticals Inc | ACAD | Biotechnology | 15.1 | 2.50B | -0.20% | 82.58 | 11.16% |
Agios Pharmaceuticals Inc | AGIO | Biotechnology | 41.325 | 2.48B | -1.11% | n/a | 9.78% |
Structure Therapeutics Inc. American Depositary Shares | GPCR | Biotechnology | 42.99 | 2.46B | -1.15% | n/a | 0.51% |
SPRINGWORKS THERAPEUTICS INC. | SWTX | Biotechnology | 32.64 | 2.42B | -0.58% | n/a | 1.27% |
IBRX | IBRX | Biotechnology | 3.43 | 2.39B | -3.92% | n/a | -143.04% |
Janux Therapeutics Inc. Common Stock | JANX | Biotechnology | 45.02 | 2.35B | 3.61% | n/a | 3.62% |
Arrowhead Pharmaceuticals Inc | ARWR | Biotechnology | 18.82 | 2.34B | -2.08% | n/a | 137.39% |
KEROS THERAPEUTICS INC. | KROS | Biotechnology | 60.9 | 2.30B | -0.67% | n/a | 3.32% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
HNI Corporation | HNI | Building Products & Equipment | 53.27 | 2.51B | 0.72% | 21.28 | 76.47% |
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.42 | 1.68B | 0.17% | 42.66 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 57.84 | 1.66B | 0.98% | 21.48 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.60 | 0.76 | Cheaper |
Ent. to Revenue | - | 3,674.48 | - |
PE Ratio | - | 38.01 | - |
Price to Book | 7.26 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 47.21 | 74.67 | Lower Risk |
Debt to Equity | 0.16 | -1.82 | Expensive |
Debt to Assets | 0.13 | 0.26 | Cheaper |
Market Cap | 2.35B | 3.73B | Emerging |